
#249 – Albert Bourla: Pfizer CEO
Lex Fridman Podcast
 00:00 
Advancements in COVID Treatment: Paxlovid vs Ivermectin
This chapter explores the development and emergency use of Pfizer's antiviral treatment, Paxlovid, aimed at reducing COVID-related hospitalizations. It also critically examines the controversial discussions surrounding ivermectin and emphasizes the importance of evidence-based medicine amidst ongoing debates about treatment efficacy.
 Play episode from 01:05:39 
 Transcript 


